MediWound Ltd. (MDWD)
12.86
-0.11
(-0.85%)
USD |
NASDAQ |
Aug 26, 09:59
MediWound Debt to Equity Ratio : 0.2676 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.2676 |
| March 31, 2026 | 0.2186 |
| December 31, 2025 | 0.2011 |
| September 30, 2025 | 0.186 |
| June 30, 2025 | 0.442 |
| March 31, 2025 | 0.2274 |
| December 31, 2024 | 0.2225 |
| September 30, 2024 | 0.2099 |
| June 30, 2024 | 0.4394 |
| March 31, 2024 | 0.3452 |
| December 31, 2023 | 0.2124 |
| September 30, 2023 | 0.1796 |
| June 30, 2023 | 0.0194 |
| March 31, 2023 | 0.0223 |
| December 31, 2022 | 0.1263 |
| September 30, 2022 | 2.061 |
| June 30, 2022 | -1.580 |
| March 31, 2022 | 0.637 |
| December 31, 2021 | -0.4343 |
| September 30, 2021 | -4.080 |
| June 30, 2021 | 1.551 |
| March 31, 2021 | 0.7213 |
| December 31, 2020 | 0.3172 |
| September 30, 2020 | 0.3508 |
| June 30, 2020 | 0.3145 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.2577 |
| December 31, 2019 | 0.1698 |
| September 30, 2019 | 0.11 |
| June 30, 2019 | 0.1112 |
| March 31, 2019 | 0.3974 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.0029 |
| June 30, 2014 | 0.0058 |
| March 31, 2014 | 0.0055 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Teva Pharmaceutical Industries Ltd. | 2.176 |
| RedHill Biopharma Ltd. | -- |
| Purple Biotech Ltd. | 0.0109 |
| Sol-Gel Technologies Ltd. | 0.016 |
| PolyPid Ltd. | 0.2918 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 71.88M |
| Total Liabilities (Quarterly) | 27.45M |
| Shareholders Equity (Quarterly) | 35.64M |
| Current Ratio | 2.316 |
| Net Debt Paydown Yield | -0.26% |